Filter By:
04:42
At the Thirteenth International Kidney Cancer Symposium, Dr Sumanta Pal (City of Hope Comprehensive Cancer Center, CA) discusses papillary renal cell carcinoma (pRCC) and the new AstraZeneca-spo​nsored Phase 2 clinical trial on the MET inhibitor, volitinib, in patients with pRCC. Although pRCC co...
by:EMJ | 31 views
04:57
On location in Madrid, Spain at the ESMO (European Society Medical for Medical Oncology) Conference, Dr. Celestia “Tia” Higano from the Seattle Cancer Care Alliance, joined Patient Power to discuss news coming out of the conference that is significant for patients. She shared information about the role of chemotherapy in men with newly diagnosed m...
by:patientpower | 18 views
03:00
Description: At the Thirteenth International Kidney Cancer Symposium, Dr Laurence Albiges (Gustave Roussy, France) provides an overview of papillary renal cell carcinoma (pRCC) and management options for these patients. pRCC comprises 10–15% of renal cell carcinoma and specific therapies are not ava...
by:EMJ | 54 views
06:11
At the Thirteenth International Kidney Cancer Symposium, Dr Toni Choueiri (Dana-Farber Cancer Institute and Harvard Medical School, MA) discusses the new AstraZeneca-spo​nsored Phase 2 clinical trial on the c-Met inhibitor, volitinib, in patients with papillary renal cell carcinoma (pRCC). pRCC i...
by:EMJ | 83 views
04:56
At the Thirteenth International Kidney Cancer Symposium, Dr James Hsieh (Memorial Sloan-Kettering Cancer Center, NY) discusses chromophobe renal cell carcinoma (RCC), which comprises 5% of RCC. Chromophobe RCC variants are important determinants in current treatment options. The incidence of incurab...
by:EMJ | 66 views
03:40
At the Thirteenth International Kidney Cancer Symposium, Dr JianJun Gao (University of Texas MD Anderson Cancer Center, TX) provides an overview of renal medullary carcinoma (RMC). RMC is a rare and aggressive renal cell carcinoma subtype that primarily occurs in African-America​n patients with sickl...
by:EMJ | 49 views
04:05
At the Thirteenth International Kidney Cancer Symposium, Dr Hans Hammers (Johns Hopkins, MD) encourages kidney cancer patients to take an active role in health care. Currently, a strategic and patient-tailore​d approach is recommended in kidney cancer management. Dr Hammers discusses how clinical tri...
by:EMJ | 90 views
02:47
At the Thirteenth International Kidney Cancer Symposium, Dr Elizabeth Plimack (Fox Chase Cancer Center, PA) discusses highlights from the Thirteenth International Kidney Cancer Symposium. This meeting provides a forum for a varied audience with an interest in renal cell carcionoma (RCC) to excha...
by:EMJ | 74 views
02:02
At the Thirteenth International Kidney Cancer Symposium, Dr Laurence Albiges (Gustave Roussy, France) discusses the new AstraZeneca-spo​nsored Phase 2 clinical trial on the MET inhibitor, volitinib, in patients with papillary renal cell carcinoma (pRCC). Inappropriate MET activation in cancer cells m...
by:EMJ | 41 views
01:31
At the Thirteenth International Kidney Cancer Symposium, Dr Abraham Ari Hakimi (Memorial Sloan-Kettering Cancer Center, NY) discusses the current understanding of sarcomatoid renal cell carcinoma (RCC). Sarcomatoid RCC is an aggressive subtype of RCC and presents significant clinical challenges. Mod...
by:EMJ | 73 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)